Provided by Tiger Trade Technology Pte. Ltd.

Haemonetics

79.98
-1.1300-1.39%
Post-market: 79.980.00000.00%16:10 EST
Volume:886.06K
Turnover:71.23M
Market Cap:3.74B
PE:23.28
High:82.41
Open:80.80
Low:79.23
Close:81.11
52wk High:87.32
52wk Low:47.32
Shares:46.81M
Float Shares:46.81M
Volume Ratio:0.79
T/O Rate:1.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.44
EPS(LYR):3.33
ROE:19.47%
ROA:6.36%
PB:4.41
PE(LYR):24.01

Loading ...

Haemonetics (HAE): Assessing Valuation After Profit Beat and Completion of Major Buyback

Simply Wall St.
·
Nov 14

Director Makes Bold Move with Major Haemonetics Stock Purchase

TIPRANKS
·
Nov 13

Director Mark W. Kroll Reports Acquisition of Haemonetics Corporation Common Shares

Reuters
·
Nov 13

Pharvaris Reports Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire
·
Nov 12

Data Supporting the Potentially Differentiated Pharvaris Portfolio Presented at ACAAI 2025 Annual Scientific Meeting

GlobeNewswire
·
Nov 10

Haemonetics Corp : Mizuho Raises Target Price to $75 From $65

THOMSON REUTERS
·
Nov 10

Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

GlobeNewswire
·
Nov 09

BUZZ-U.S. STOCKS ON THE MOVE-Novo Nordisk, Block, Peloton Interactive

Reuters
·
Nov 08

Haemonetics Taking Prudent View on Guidance After Plasma Recovery, BofA Says

MT Newswires Live
·
Nov 08

BUZZ-Haemonetics rises after BofA upgrades to "neutral" on prudent growth forecast

Reuters
·
Nov 07

Stock Track | Haemonetics Soars 5.27% as Needham Raises Price Target to $78

Stock Track
·
Nov 07

Haemonetics Corp : Bofa Global Research Raises to Neutral From Underperform; Raises Price Objective to $75 From $58

THOMSON REUTERS
·
Nov 07

Haemonetics upgraded to Neutral from Underperform at BofA

TIPRANKS
·
Nov 07

Needham Raises Price Target on Haemonetics to $78 From $68, Keeps Buy Rating

MT Newswires Live
·
Nov 07

U.S. RESEARCH ROUNDUP-Blackline, Carmax, Expedia

Reuters
·
Nov 07

Stock Track | Haemonetics Soars 33.75% on Strong Q2 Earnings Beat and Raised Guidance

Stock Track
·
Nov 07

Haemonetics: Strong Financial Performance and Strategic Adjustments Drive Buy Rating

TIPRANKS
·
Nov 07

Sector Update: Health Care Stocks Softer in Afternoon Trading

MT Newswires Live
·
Nov 07

Haemonetics Is Maintained at Buy by BTIG

Dow Jones
·
Nov 07

Haemonetics Shares Gain on Higher 2Q Profit, Outlook Boost

Dow Jones
·
Nov 07